488 related articles for article (PubMed ID: 27050275)
1. Post-treatment serum lactic dehydrogenase as a predictive indicator for distant metastasis and survival of patients with nasopharyngeal carcinoma.
Wang J; Li L; Dong BQ; Xu YJ; Zheng YD; Sun ZW; Yang Y; Chen YY; Chen XZ; Chen M
Oncotarget; 2016 May; 7(19):27458-67. PubMed ID: 27050275
[TBL] [Abstract][Full Text] [Related]
2. Pretreatment Serum Lactate Dehydrogenase Level as an Independent Prognostic Factor of Nasopharyngeal Carcinoma in the Intensity-Modulated Radiation Therapy Era.
Chen Z; Guo Q; Lu T; Lin S; Zong J; Zhan S; Xu L; Pan J
Med Sci Monit; 2017 Jan; 23():437-445. PubMed ID: 28120819
[TBL] [Abstract][Full Text] [Related]
3. Prognostic implications of dynamic serum lactate dehydrogenase assessments in nasopharyngeal carcinoma patients treated with intensity-modulated radiotherapy.
Zhou GQ; Ren XY; Mao YP; Chen L; Sun Y; Liu LZ; Li L; Lin AH; Mai HQ; Ma J
Sci Rep; 2016 Mar; 6():22326. PubMed ID: 26928265
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value and predictive threshold of tumor volume for patients with locally advanced nasopharyngeal carcinoma receiving intensity-modulated radiotherapy.
He YX; Wang Y; Cao PF; Shen L; Zhao YJ; Zhang ZJ; Chen DM; Yang TB; Huang XQ; Qin Z; Dai YY; Shen LF
Chin J Cancer; 2016 Nov; 35(1):96. PubMed ID: 27852284
[TBL] [Abstract][Full Text] [Related]
5. Baseline serum lactate dehydrogenase levels for patients treated with intensity-modulated radiotherapy for nasopharyngeal carcinoma: a predictor of poor prognosis and subsequent liver metastasis.
Zhou GQ; Tang LL; Mao YP; Chen L; Li WF; Sun Y; Liu LZ; Li L; Lin AH; Ma J
Int J Radiat Oncol Biol Phys; 2012 Mar; 82(3):e359-65. PubMed ID: 22000748
[TBL] [Abstract][Full Text] [Related]
6. Effect of adaptive replanning in patients with locally advanced nasopharyngeal carcinoma treated by intensity-modulated radiotherapy: a propensity score matched analysis.
Luo Y; Qin Y; Lang J
Clin Transl Oncol; 2017 Apr; 19(4):470-476. PubMed ID: 27718153
[TBL] [Abstract][Full Text] [Related]
7. Treatment outcomes and late toxicities of 869 patients with nasopharyngeal carcinoma treated with definitive intensity modulated radiation therapy: new insight into the value of total dose of cisplatin and radiation boost.
Ou X; Zhou X; Shi Q; Xing X; Yang Y; Xu T; Shen C; Wang X; He X; Kong L; Ying H; Hu C
Oncotarget; 2015 Nov; 6(35):38381-97. PubMed ID: 26485757
[TBL] [Abstract][Full Text] [Related]
8. Pretreatment prognostic factors of survival and late toxicities for patients with nasopharyngeal carcinoma treated by simultaneous integrated boost intensity-modulated radiotherapy.
Lin YH; Huang TL; Chien CY; Chen HC; Hsu HC; Huang EY; Wang CJ; Huang YJ; Wang YM; Huang CC; Chou SY; Liao KC; Fang FM
Radiat Oncol; 2018 Mar; 13(1):45. PubMed ID: 29554940
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the treatment outcomes of intensity-modulated radiotherapy and two-dimensional conventional radiotherapy in nasopharyngeal carcinoma patients with parapharyngeal space extension.
Tang LL; Chen L; Mao YP; Li WF; Sun Y; Liu LZ; Lin AH; Mai HQ; Shao JY; Li L; Ma J
Radiother Oncol; 2015 Aug; 116(2):167-73. PubMed ID: 26316395
[TBL] [Abstract][Full Text] [Related]
10. Primary tumor inflammation in gross tumor volume as a prognostic factor for nasopharyngeal carcinoma patients.
Peng H; Chen L; Tang LL; Zhang Y; Li WF; Mao YP; Zhang F; Guo R; Liu LZ; Tian L; Lin AH; Sun Y; Ma J
Oncotarget; 2016 Mar; 7(12):14963-72. PubMed ID: 26934649
[TBL] [Abstract][Full Text] [Related]
11. Retrospective Analysis of the Survival Benefit of Induction Chemotherapy in Stage IVa-b Nasopharyngeal Carcinoma.
Lan XW; Zou XB; Xiao Y; Tang J; OuYang PY; Su Z; Xie FY
PLoS One; 2016; 11(8):e0160758. PubMed ID: 27509025
[TBL] [Abstract][Full Text] [Related]
12. Investigation of long-term survival outcomes and failure patterns of patients with nasopharyngeal carcinoma receiving intensity-modulated radiotherapy: a retrospective analysis.
Zhao W; Lei H; Zhu X; Li L; Qu S; Liang X
Oncotarget; 2016 Dec; 7(52):86914-86925. PubMed ID: 27894100
[TBL] [Abstract][Full Text] [Related]
13. Intensity-modulated radiotherapy prolongs the survival of patients with nasopharyngeal carcinoma compared with conventional two-dimensional radiotherapy: A 10-year experience with a large cohort and long follow-up.
Zhang MX; Li J; Shen GP; Zou X; Xu JJ; Jiang R; You R; Hua YJ; Sun Y; Ma J; Hong MH; Chen MY
Eur J Cancer; 2015 Nov; 51(17):2587-95. PubMed ID: 26318726
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the seventh and eighth editions of the UICC/AJCC staging system for nasopharyngeal carcinoma: analysis of 1317 patients treated with intensity-modulated radiotherapy at two centers.
Yang XL; Wang Y; Liang SB; He SS; Chen DM; Chen HY; Lu LX; Chen Y
BMC Cancer; 2018 May; 18(1):606. PubMed ID: 29843648
[TBL] [Abstract][Full Text] [Related]
15. Prognostic Value of Cavernous Sinus Invasion in Patients with Nasopharyngeal Carcinoma Treated with Intensity-Modulated Radiotherapy.
Liao JF; Ma L; Du XJ; Lan M; Guo Y; Zheng L; Xia YF; Luo W
PLoS One; 2016; 11(1):e0146787. PubMed ID: 26824230
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of MRI-derived masticator space involvement in IMRT-treated nasopharyngeal carcinoma patients.
Xiao Y; Pan J; Chen Y; Lin S; Chen Y; Zong J; Fang Y; Guo Q; Chen B; Tang L
Radiat Oncol; 2015 Sep; 10():204. PubMed ID: 26407897
[TBL] [Abstract][Full Text] [Related]
17. Combined prognostic value of pretreatment anemia and cervical node necrosis in patients with nasopharyngeal carcinoma receiving intensity-modulated radiotherapy: A large-scale retrospective study.
Zhang LL; Zhou GQ; Li YY; Tang LL; Mao YP; Lin AH; Ma J; Qi ZY; Sun Y
Cancer Med; 2017 Dec; 6(12):2822-2831. PubMed ID: 29034992
[TBL] [Abstract][Full Text] [Related]
18. Survival analysis of patients with advanced-stage nasopharyngeal carcinoma according to the Epstein-Barr virus status.
Peng H; Chen L; Zhang Y; Guo R; Li WF; Mao YP; Tan LL; Sun Y; Zhang F; Liu LZ; Tian L; Lin AH; Ma J
Oncotarget; 2016 Apr; 7(17):24208-16. PubMed ID: 27008701
[TBL] [Abstract][Full Text] [Related]
19. Pretreatment Serum Lactate Dehydrogenase and N Classification Predict Long-Term Survival and Distant Metastasis in Patients With Nasopharyngeal Carcinoma Who Have A Positive Family History of Cancer.
Zhang W; Chen Y; Zhou G; Liu X; Chen L; Tang L; Mao Y; Sun Y; Ma J
Medicine (Baltimore); 2015 Sep; 94(37):e1505. PubMed ID: 26376394
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of masticatory muscle involvement in nasopharyngeal carcinoma patients treated with intensity-modulated radiation therapy.
Kang M; Zhou P; Liao X; Xu M; Wang R
Oral Oncol; 2017 Dec; 75():100-105. PubMed ID: 29224805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
